Moderate alcohol consumption in middle age can lower ca...(an increase in mortality in a four-year ...),Health
Navigation Links
Moderate alcohol consumption in middle age can lower cardiac risk
Date:3/7/2008
an increase in mortality in a four-year follow up period. The findings suggest that, for carefully selected individuals, a heart healthy diet may include limited alcohol consumption even among individuals who have not included alcohol previously.
'/>"/>
| Contact: Pamela Poppalardo ajmmedia@elsevier.com 212-633-3944 Elsevier Health Sciences Source:Eurekalert |
Related medicine news :
1. A Drug With Efficacy Superior to That of Memantine Would Earn up to a 50% Patient Share in the Moderate-to-Severe Alzheimers Disease Drug Market
2. Moderate Aerobic Fitness Levels May Cut Stroke Risk
3. Gene variant linked to moderated symptoms of beta-thalassemia
4. Moderate Exercise Cuts Risk of Metabolic Syndrome
5. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
6. Research Shows Alcohol Can Benefit the Hearts of New Drinkers
7. U of Minn researchers find primary alcohol prevention programs are needed for tweens
8. Alcoholics underestimate the risk of bleeding
9. Gene variant predicts medication response in patients with alcohol dependence
10. Eye Blinks May ID Fetal Alcohol Exposure
11. Parental Drinking Boosts Teen Alcohol Risks
Post Your Comments:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3...Susan Butcher the famous iditarod champion was det...rticipate in the 300-mile sled dog race conducted ...of the 1100-mile Iditarod Trail Sled Dog Race. She...ce of survival with the same grit and confidence. ...
...There appears to be a remarkable laxity among the ...ng skin cancer. Felipe Beltran, the spokesman for ... has admitted that the organization’s drive agains...ed impact. The online study of the QIMR did not e...
...Researchers from Germany have discovered a novel, ...of coronary veins. This technique, called ECG-gate...DCT, is associated with very few complications // ... improved diagnostic quality and treatment. A com...
...A research was conducted by Selda Samakoglu and co...nter. This research opened new doors in the treatm.... The treatment combines both gene therapy and RNA...eatment has worked well in the laboratory stage an...
Other Medicine News:Health News:Treatment of Sickle Cell Anemia Using Gene Therapy. 2(Date:10/6/2008)...E Therapy is More Likely to Induce Steroid-Free ...rd Immunomodulator, Azathiopri...esented for the first time,from the Phase 3b Study...odulators and Biologic Therapy (SONIC) may provide...s with moderate to severe Crohn,s disease.,Accordi...
(Date:10/6/2008)...Oct. 6 /- Complete,Genomics Inc., a n...ncing,company, and the Institute for Systems Biolo...uct populationwide human genome studies., In phas...ts proprietary,DNA sequencing technology to sequen..., once proof-of-concept has been demonstrated, ISB...
(Date:10/6/2008)...d for 9:00 AM ET Today -, SEATTLE, Oct. 6 /PRNews...NDN) announced today that it has completed the pla...double-blind, placebo-controlled IMPACT,(IMmunothe...nown as D9902B),clinical trial designed to assess ...ive cellular immunotherapy PROVENGE(R) (sipuleucel...
(Date:10/6/2008)...6 Weeks of Radiation Therapy -, Event: Watch Singl...sday, October 22, 2008, 3 - 4 p.m. by visiting ...Va., Oct. 6 / Questions raced through...st cancer in May. Would she have the,tumor removed...otherapy?, , To view the Multimedia News Release...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 4037 1FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 4037 2Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 1Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 2Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 3Pharmacopeia to Receive 245 Million Payment from GlaxoSmithKline 4034 4DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 1DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 2TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 1TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 2[0] New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study[0] Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study[0] Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial[0] Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial
...wswire/ -- D-Pharm announced,today that the result...ompound DP-b99 in the treatment of acute ischemic,...Stroke,Conference. The data will be presented by t...C. Diener, on Thursday May 31st at,14.30 in the Ca...enter in Glasgow. The abstract for the presentatio...
... and on three investigational,agents (VEGF Trap, S...nual ASCO meeting, BRIDGEWATER, N.J., May 29, 2007...d today that a total of 375 abstracts,indicative o...he,43rd Annual Meeting of the American Society of ...e 1-5, 2007). The results from key,studies involvi...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12Basic-level interpretive resting ECG
Mid-level interpretive resting ECG
Cruise Control is a device developed by STAAR as a filter between the phaco handpiece and aspiration tubing that captures nuclear material, enhances the safety and efficiency of phaco procedures by e
...rovides the ultimate flexibility for performing sl... a patient room or in the sleep laboratory. Travel...an VISION analysis software as your in-lab studies...f many powerful Sleepscan features such as the VIS...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |